Published in Infect Immun on March 01, 1975
Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med (2003) 3.86
Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acid. Antimicrob Agents Chemother (1978) 1.57
Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J Virol (1998) 1.47
Treatment of experimental herpesvirus infections with phosphonoformate and some comparisons with phosphonoacetate. Antimicrob Agents Chemother (1978) 1.21
Influence of ovarian hormones on urogenital infection. Sex Transm Infect (1998) 1.19
Pathogenesis of herpes simplex virus types 1 and 2 in mice after various routes of inoculation. Infect Immun (1976) 1.02
Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs. J Virol (1985) 0.96
Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection. J Control Release (2012) 0.95
Potent adjuvant activity of cationic liposome-DNA complexes for genital herpes vaccines. Clin Vaccine Immunol (2009) 0.86
Antiviral activity of extracts from marine algae. Antimicrob Agents Chemother (1978) 0.84
Virus spread and initial pathological changes in the nervous system in genital herpes simplex virus type 2 infection in mice. A correlative immunohistochemical, light and electron microscopic study. Acta Neuropathol (1987) 0.84
Criteria for development of animal models of diseases of the reproductive system. Am J Pathol (1980) 0.83
Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules. Immunology (2000) 0.82
Recurrent vaginal shedding of herpes simplex type 2 virus in the mouse and effects of antiviral therapy. Antiviral Res (2010) 0.80
Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculated mice. Antimicrob Agents Chemother (1984) 0.79
A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2. J Virol (2015) 0.75
Efficacy of the acyclic guanosine analog buciclovir [(R)-9-(3,4-dihydroxybutyl)guanine] in experimental genital herpes. Antimicrob Agents Chemother (1986) 0.75
Latent herpes simplex virus in spinal ganglia of mice. Science (1971) 7.04
Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med (1973) 5.66
Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med (1974) 4.49
Depressed maternal lymphocyte response to phytohaemagglutinin in human pregnancy. Lancet (1972) 4.47
Infection with herpes-simplex viruses 1 and 2. 1. N Engl J Med (1973) 2.87
Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy. Science (1974) 2.71
Infection of the newborn with herpesvirus hominis. Adv Pediatr (1970) 2.61
Comparative studies of type 1 and type 2 & 'herpes simplex' viruses. Br J Exp Pathol (1968) 2.56
Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine. J Infect Dis (1973) 2.53
Different patterns of neurologic involvement with herpes simplex virus types 1 and 2: isolation of herpes simplex virus type 2 from the buffy coat of two adults with meningitis. J Infect Dis (1973) 2.52
Latent herpes simplex virus in the central nervous system of rabbits and mice. J Exp Med (1973) 2.48
Genital infection with type 2 Herpes virus hominis. A commonly occurring venereal disease. Br J Vener Dis (1969) 2.40
Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am J Obstet Gynecol (1958) 2.02
Genital herpes simplex infection. Virologic and cytologic studies. Obstet Gynecol (1967) 1.95
Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. J Infect Dis (1973) 1.54
Herpes simplex virus in mice: electron microscopy of neural spread. Science (1968) 1.49
Hepres genitalis; clinical and cytopathologic experience with 256 patients. Obstet Gynecol (1970) 1.42
Morphological studies of the neural spread of herpes simplex virus to the central nervous system. Acta Neuropathol (1970) 1.32
Herpesvirus hominis infection of the female genital tract. Obstet Gynecol (1972) 1.31
The relation of sex, pregnancy and menstruation to susceptibility in poliomyelitis. N Engl J Med (1951) 1.28
Factors Modifying Host Resistance to Virus Infection: II. Enhanced Susceptibility of Mice to Encephalomyocarditis Virus Infection During Pregnancy. Am J Pathol (1968) 1.13
Idoxuridine in herpes simplex virus (type 1) encephalitis. Experience with 29 cases in Michigan, 1966 to 1971. Ann Intern Med (1973) 1.12
Herpes simplex virus and paralysis of animals. Br J Exp Pathol (1966) 1.12
Relief for Herpes vulvitis. Obstet Gynecol (1973) 1.00
Peripheral blood lymphocyte responses to phytohemagglutinin and pokeweed mitogen during pregnancy. Proc Soc Exp Biol Med (1974) 1.00
Ultrastructure of herpes simplex virus infection of the nervous system of mice. Acta Neuropathol (1973) 0.99
Genital herpesvirus hominis Type 2 infection of monkeys. Obstet Gynecol (1971) 0.96
Genital herpesvirus hominis type 2 infection: an experimental model in cebus monkeys. Science (1971) 0.94
Cytarabine for herpesvirus infections. JAMA (1972) 0.91
Effect of pregnancy and hypertension on reticuloendothelial activity. Am J Obstet Gynecol (1970) 0.88
Experimental genital infection of cebus monkeys with oral and genital isolates of Herpesvirus hominis types 1 and 2. Arch Gesamte Virusforsch (1972) 0.83
Clinical observations and neuropathology of rabbits in the acute stages of type 2 herpes simplex infections. Br J Exp Pathol (1973) 0.82
Experimental genital herpes infection of the marmoset. J Med Primatol (1973) 0.80
Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science (1990) 6.70
The staphylococcal scalded-skin syndrome. N Engl J Med (1970) 5.33
The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med (1977) 3.61
The staphylococcal scalded-skin syndrome: isolation and partial characterization of the exfoliative toxin. J Infect Dis (1972) 3.45
Cellular immunity in host resistance to viral infections. Arch Intern Med (1970) 2.79
Leukocytes and interferon in the host response to viral infections. II. Enhanced interferon response of leukocytes from immune animals. J Bacteriol (1966) 2.78
Neonatal bacterial meningitis. Analysis of predisposing factors and outcome compared with matched control subjects. J Pediatr (1970) 2.62
Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models. J Clin Invest (1993) 2.59
Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine. J Infect Dis (1973) 2.53
Nature of the genetic determinant controlling exfoliative toxin production in Staphylococcus aureus. J Bacteriol (1974) 2.23
Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J Infect Dis (1982) 2.16
Staphylococcal scalded skin syndrome: the expanded clinical syndrome. J Pediatr (1971) 2.11
Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA (1989) 2.09
Rapid detection of herpes simplex virus in clinical specimens by centrifugation and immunoperoxidase staining. J Clin Microbiol (1986) 2.06
The effects of blinding on acceptance of research papers by peer review. JAMA (1994) 2.00
The course of untreated recurrent genital herpes simplex infection in 27 women. N Engl J Med (1981) 1.89
Isolation of extrachromosomal deoxyribonucleic acid for exfoliative toxin production from phage group II Staphylococcus aureus. J Bacteriol (1975) 1.88
Interferon and cytomegalovirus in vivo and in vitro. Proc Soc Exp Biol Med (1967) 1.85
Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J Infect Dis (1982) 1.72
Effect of ethidium bromide on elimination of exfoliative toxin and bacteriocin production in Staphylococcus aureus. J Bacteriol (1974) 1.69
Clustering of necrotizing enterocolitis. Interruption by infection-control measures. N Engl J Med (1977) 1.67
Phage group II staphylococcal strains with chromosomal and extrachromosomal genes for exfoliative toxin production. Infect Immun (1976) 1.66
Bacterial tracheitis. JAMA (1979) 1.64
(Z)- and (E)-2-((hydroxymethyl)cyclopropylidene)methyladenine and -guanine. New nucleoside analogues with a broad-spectrum antiviral activity. J Med Chem (1998) 1.61
Factors modifying host resistance to viral infection. 3. Effect of whole body x-irradiation on experimental encephalomyocarditis virus infection in mice. J Exp Med (1968) 1.61
Genital Herpesvirus homonis infection in mice. II. Treatment with phosphonoacetic acid, adenine arabinoside, and adenine arabinoside 5'-monophosphate. J Infect Dis (1977) 1.60
Characterization of atypical Candida tropicalis and other uncommon clinical yeast isolates. J Clin Microbiol (1982) 1.59
Infant botulism: clinical spectrum and epidemiology. Pediatrics (1980) 1.58
Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acid. Antimicrob Agents Chemother (1978) 1.57
Differential susceptibility of male and female mice to encephalomyocarditis virus: effects of castration, adrenalectomy, and the administration of sex hormones. Infect Immun (1972) 1.56
Immunologic responses to Hemophilus influenzae meningitis. J Pediatr (1972) 1.53
Antibiograms, serotypes, and plasmid profiles of Pseudomonas aeruginosa associated with corneal ulcers and contact lens wear. J Clin Microbiol (1986) 1.53
Nosocomial infections in a newborn intensive-care unit. Results of forty-one months of surveillance. N Engl J Med (1976) 1.50
Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. Antimicrob Agents Chemother (2000) 1.49
Inhibition of murine osteogenic sarcomas by treatment with type I or type II interferon. J Natl Cancer Inst (1978) 1.49
Teenagers' preferences regarding the presence of family members, peers, and chaperones during examination of genitalia. Pediatrics (1981) 1.48
Association of Pseudomonas and Serratia corneal ulcers with use of contaminated solutions. J Clin Microbiol (1987) 1.45
Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections. Infect Immun (1976) 1.44
Comparison of antiviral and antitumor activity of activated macrophages. Cell Immunol (1977) 1.42
More rapid isolation of herpes simplex virus in a continuous line of mink lung cells than in Vero or human fibroblast cells. Diagn Microbiol Infect Dis (1984) 1.39
Benchmark indicators for medical equipment repair and maintenance. Biomed Instrum Technol (1995) 1.38
Synergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Hemophilus influenza. J Infect Dis (1968) 1.36
Pseudomonas corneal ulcers associated with soft contact-lens wear. Am J Ophthalmol (1981) 1.32
Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus. J Infect Dis (1977) 1.32
Differences in neurovirulence among isolates of Herpes simplex virus types 1 and 2 in mice using four routes of infection. J Infect Dis (1981) 1.29
Acyclovir treatment of experimental genital herpes simplex virus infections. Am J Med (1982) 1.29
Tilorone hydrochloride: an oral interferon-inducing agent. Antimicrob Agents Chemother (1972) 1.28
Transfer of interferon-producing macrophages: new approach to viral chemotherapy. Science (1970) 1.27
Alteration of host defense mechanisms by murine cytomegalovirus infection. Infect Immun (1977) 1.25
Induction of interferon in ovine and human lymphocyte cultures by mycoplasmas. Infect Immun (1976) 1.24
Site of action of exfoliative toxin in the staphylococcal scaled-skin syndrome. Pediatrics (1972) 1.23
Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents. Infect Immun (1972) 1.23
Evidence for an altered operator specificity: catabolite repression control of the leucine operon in Salmonella typhimurium. J Bacteriol (1968) 1.23
Automated, quantitative cytopathic effect reduction assay for interferon. J Clin Microbiol (1982) 1.22
Summary of the II International Symposium on Cytomegalovirus. Antiviral Res (1998) 1.21
Sexual activity, contraception, genital infections, and cervical cancer: support for a sexually transmitted disease hypothesis. Am J Epidemiol (1989) 1.21
Treatment of experimental herpesvirus infections with phosphonoformate and some comparisons with phosphonoacetate. Antimicrob Agents Chemother (1978) 1.21
Effective antiviral chemotherapy in cytomegalovirus infection of mice. J Infect Dis (1976) 1.21
Effective treatment of murine cytomegalovirus infections with methylenecyclopropane analogues of nucleosides. Antiviral Res (1999) 1.20
Recurrent genital herpes simplex virus infection in guinea pigs. Intervirology (1985) 1.20
Sequential production of IFN-alpha and immune-specific IFN-gamma by human mononuclear leukocytes exposed to herpes simplex virus. J Immunol (1981) 1.20
Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille calmette-guérin. J Infect Dis (1977) 1.20
Isoprinosine: lack of antiviral activity in experimental model infections. J Infect Dis (1972) 1.19
Correlation of the suppression of mitogen responsiveness and the mixed lymphocyte reaction with the proliferative response to viral antigen of splenic lymphocytes from cytomegalovirus-infected mice. J Immunol (1978) 1.19
Is vaginal douching related to cervical carcinoma? Am J Epidemiol (1991) 1.19
Course and outcome of chronic fatigue in children and adolescents. Pediatrics (1998) 1.17
Herpesvirus hominis infection in newborn mice: treatment with interferon inducer polyinosinic-polycytidylic acid. Antimicrob Agents Chemother (1975) 1.17
(Z)- and (E)-2-(hydroxymethylcyclopropylidene)-methylpurines and pyrimidines as antiviral agents. Antivir Chem Chemother (1998) 1.17
Gluconate regulation of glucose catabolism in Pseudomonas fluorescens. J Bacteriol (1972) 1.15
Effect of cytosine arabinoside and 5-iodo-2'-deoxyuridine on a cytomegalovirus infection in newborn mice. Antimicrob Agents Chemother (1976) 1.15
Staphylococcal scalded-skin syndrome: development of a primary binding assay for human antibody to the exfoliative toxin. Infect Immun (1976) 1.15
In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections. Antivir Chem Chemother (2001) 1.15